Results 161 to 170 of about 8,164,322 (359)

Inhibition of CDK9 enhances AML cell death induced by combined venetoclax and azacitidine

Molecular Oncology, EarlyView.
The CDK9 inhibitor AZD4573 downregulates c‐MYC and MCL‐1 to induce death of cytarabine (AraC)‐resistant AML cells. This enhances VEN + AZA‐induced cell death significantly more than any combination of two of the three drugs in AraC‐resistant AML cells.
Shuangshuang Wu, Jianlei Zhao, Aaban Asfar Azmi, Avanti Gupte, Jenna Thibodeau, Shuang Liu, Jinli Yang, Guan Wang, Holly Edwards, Lisa A. Polin, Juiwanna Kushner, Sijana H. Dzinic, Kathryn White, Julie Boerner, Maik Hüttemann, Jay Yang, Yue Wang, Jeffrey W. Taub, Yubin Ge   +18 more
wiley   +1 more source

Patterns of drug prescription among hospitalized patients in a tertiary women's hospital: A retrospective drug utilization study. [PDF]

J Int Med Res
Omidifar N, Mahi-Birjand M, Askari P, Abolzadeh Oskuie P, Karimzadeh I, Mirjalili M, Hoorang M, Peymani P.   +7 more
europepmc   +1 more source

Impact of Food and Drug Administration Safety Communications on Drug-coated Device Utilization in Peripheral Artery Disease [PDF]

Midori P. White, Chen Dun, YH Andrew Wu, Jamie Schwartz, Jesse A. Columbo, Christopher J. Abularrage, Ying Wei Lum, James H. Black, Caitlin W. Hicks   +8 more
openalex   +1 more source

Anti-epileptic drug utilization and treatment outcome among epileptic patients on follow-up in a resource poor setting [PDF]

, 2014
Mesfin Gurshaw, Asrat Agalu, Tesfahun Chanie   +2 more
openalex   +1 more source

A synthetic benzoxazine dimer derivative targets c‐Myc to inhibit colorectal cancer progression

Molecular Oncology, EarlyView.
Benzoxazine dimer derivatives bind to the bHLH‐LZ region of c‐Myc, disrupting c‐Myc/MAX complexes, which are evaluated from SAR analysis. This increases ubiquitination and reduces cellular c‐Myc. Impairing DNA repair mechanisms is shown through proteomic analysis.
Nicharat Sriratanasak, Bodee Nutho, Worawat Wattanathana, Narumon Phaonakrop, Bunnatut Panasawatwong, Katharina Erlenbach‐Wuensch, Sittiruk Roytrakul, Regine Schneider‐Stock, Pithi Chanvorachote   +8 more
wiley   +1 more source

Evaluation of Pharmacotherapeutic Patterns in Patients With Renal Impairment Undergoing Hemodialysis: A Drug Utilization Study. [PDF]

Cureus
Kanjariya D, Sinha A, Vaniya H, Rathva T, Makvana A.   +4 more
europepmc   +1 more source

Drug utilization evaluation of analgesics in tertiary care dental hospital in Dhule district

, 2016
Nitin D. Pise, Swapnil B. Kaikade
openalex   +2 more sources

Adaptaquin is selectively toxic to glioma stem cells through disruption of iron and cholesterol metabolism

Molecular Oncology, EarlyView.
Adaptaquin selectively kills glioma stem cells while sparing differentiated brain cells. Transcriptomic and proteomic analyses show Adaptaquin disrupts iron and cholesterol homeostasis, with iron chelation amplifying cytotoxicity via cholesterol depletion, mitochondrial dysfunction, and elevated reactive oxygen species.
Adrien M. Vaquié, Davod R. Shah, Eliane E. S. Brechbühl, Michael McNicholas, Zhaoyang Xu, John H. Stockley, Laura Morcom, Diana Gold Diaz, Gemma C. Girdler, Rachel V. Seear, Gabriel Balmus, Rajiv R. Ratan, Harry Bulstrode, James A. Nathan, Manav Pathania, Kevin M. Brindle, David H. Rowitch   +16 more
wiley   +1 more source

The Use of Proton Pump Inhibitors Among Adults in Norway-A Nationwide Drug Utilization Study. [PDF]

Pharmacol Res Perspect
Fossmark R, Molnes S, Sagatun L, Salvesen Ø, Spigset O.   +4 more
europepmc   +1 more source

Prescription Drug Insurance and Its Effect on Utilization and Health of the Elderly

, 2007
Nasreen Khan, Robert Kaestner, Swu Jane Lin   +2 more
openalex   +1 more source